Are you willing to further scientific research and new drug development to benefit patients? If so, you may wish to consider becoming part of our human tissue network.
If you are:
– then we would like to discuss options with you.
At REPROCELL, we work on an individual basis with all our sites to implement the best ethical and logistical process for you, your internal systems, and our tissue needs. All tissues are used to investigate the safety or efficacy of a new drug compound or a drug combination on behalf of our pharmaceutical sponsors. Importantly, our assays provide valuable human-based data crucial to the decision-making process on progressing a novel treatment through development to the clinic. All we require from a partner tissue site is access to ethically consented fresh human tissues and a suitable collection process.
To obtain the highest quality data for drug development, our researchers only work with fresh human tissue samples. While this represents a logistical challenge for us, it ensures that donor tissue maintains functionality throughout the experimental period, providing the most biologically relevant data for analysis. Fresh tissues can be used across all stages of the drug development process, from target identification to clinical troubleshooting. Some of the tissue types that we have an increased demand for include:
An inability to obtain the necessary tissues can delay vital research necessary for novel drug development. This includes drugs that are undergoing clinical trial, where researchers are using human tissue testing to troubleshoot clinical side effects. While clinicians may have concerns about how willing patients are to consent to donation, studies show that they are likely to donate tissue for research and the greater good if asked. If you have any questions about the donation process, you can contact our clinical alliance team here.
Fresh colon tissues can be used to test a range of drug characteristics ex vivo, including drug absorption, anti-inflammatory properties, and effects on gastrointestinal (GI) motility. We use both healthy and inflammatory bowel disease (IBD) tissues to generate translational pharmacological data.
Find out more about our models that use fresh colon tissue:
Diseased and healthy fresh skin tissue can be used to measure changes in inflammatory mediators in response to topical or systemic drugs. Our team commonly test experimental compounds on samples from healthy donors and those with atopic dermatitis, psoriasis, and acne vulgaris. These tissues are typically residual to cosmetic procedures or obtained through special clinical collections.
Find out more about how we use fresh skin tissues in drug development research.
Respiratory structures contained in fresh lung tissues can be used to measure the effectiveness of test articles with a range of therapeutic properties. For example, Precision Cut Lung Slices (PCLS) can be used to investigate the efficacy of anti-inflammatory drugs while contractility can be investigated in airways of different sizes.
Our assays that can be performed using fresh lung tissue include:
On the REPROCELL blog
Latest in Drug Discovery
The Power of Human Tissue Models in Preclinical Research
03 October 2024
Understanding Safety Pharmacology in Human Tissues
26 August 2024
